Furthermore, to gain an insight into its binding ability on proteins, molecular docking simulations on HSA and MPRO (COVID-19 main virus protease) were carried out, highlighting the potential of these compounds in antitumor and anti-microbial/anti-viral therapies. The gene discussed is ALB; the disease is COVID-19.